| |
| Device | BRACAnalysis CDx® |
| Generic Name | Cancer-related germline gene mutation detection system |
| Applicant | Myriad Genetic Laboratories 320 Wakara Way Salt Lake Cit, UT 84108 |
| PMA Number | P140020 |
| Supplement Number | S022 |
| Date Received | 10/22/2021 |
| Decision Date | 03/11/2022 |
| Product Code |
PJG |
| Advisory Committee |
Pathology |
| Clinical Trials | NCT02032823
|
| Supplement Type | Normal 180 Day Track |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for inclusion of an additional clinical study (OlympiA) data in the clinical section of the labeling. |